Silk Science for Advanced Regeneration LEARN ABOUT SOFREGEN
Location: Poland, Lesser Poland Voivodeship, Krakow
Total raised: $16.1M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Anzu Partn... | anzupartne... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.12.2019 | Series B | $8M | - |
| 04.09.2019 | - | $8.1M | - |
Mentions in press and media 6
| Date | Title | Description |
| 22.01.2020 | Industrial technologies get a big backer with Anzu Partners’ new $190 million fund | Advances in biology, biochemistry, sensors and automation have the potential to reshape the ways manufacturing in America is done, and a relatively new firm called Anzu Partners has just raised $190 million to invest in companies turning th... |
| 17.12.2019 | Soft Tissue Engineering Biotechnology Company Sofregen Raises $8 Million in Series B Funding Round | We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT |
| 17.12.2019 | Sofregen Medical Lands $8M | BOSTON, MA, Sofregen Medical, (Sofregen), an early stage medical device company, announced today that it has raised $8 million in new funding. >> Click here for more funding data on Sofregen Medical >> To export Sofregen Med... |
| 17.12.2019 | Sofregen Raises $8M in Series B Funding | Sofregen Medical, Inc., a Boston, MA-based early stage medical device company, raised $8m in Series B funding. The round was led by Anzu Partners from its second venture capital fund focused on breakthrough technologies. The company intends... |
| 04.09.2019 | Sofregen raises $8.1m in equity offering | Sofregen Medical has raised more than $8 million in a stock offering, according to an SEC filing. The Medford, Mass.-based soft-tissue aesthetics company opened the offering August 16, 2019, attracting three investors who purchased $8.1 mil... |
| 15.09.2016 | Sofregen Medical Raises $6.2 Million Series A | MEDFORD, Mass.--(BUSINESS WIRE)--Sofregen Medical Inc., the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding invest... |